European Journal of Organic Chemistry · 2023 · 12 citations · 16 references
Natural SciencesChemistryMedicinal ChemistryDrug DiscoveryOrganic ChemistrySynthetic Medicinal ChemistryHeterocycle SynthesisHeterocyclic ChemistryHeterocyclic CompoundsOrganic SynthesisBicyclononyne ChemistryHeterocyclic Medicinal ChemistryHeterocyclic ReactivityMedicinal Chemistry ApplicationsMedicinal HeterocyclesPhysicochemical PropertiesSaturated Heterocycles
Abstract A straightforward approach to α‐CF 3 ‐substituted saturated bicyclic amines starting from commercially available compounds is proposed. The key steps include addition of the Ruppert‐Prakash reagent to imine moiety and AlMe 3 ‐promoted intramolecular heterocyclization. The reaction sequence provides access to fluorine‐containing azabicyclo[n.2.1]alkane (n=1–3) or azabicyclo[2.2.2]octane derivatives in 10–42 % overall yield. The physicochemical properties of the prepared compounds or their model derivatives ( i. e ., p K a and Log P ) were measured and compared to those for the parent monocyclic or non‐fluorinated saturated heterocycles. As expected, amine basicity was lowered considerably upon introduction of the CF 3 group (Δp K a ≈4), while the lipophilicity increased (by ca. 0.5 Log P units). The summarized data provides a convenient guideline for application of the synthesized compounds in drug discovery programs.
16
Two‐ and Three‐dimensional Rings in Drugs
Matteo Aldeghi, Shipra Malhotra, David L. Selwood et al. · Chemical Biology & Drug Design · 2013 · 362 citations · Full text
Next generation organofluorine containing blockbuster drugs
Jianlin Han, Attila Márió Remete, Luca S. Dobson et al. · Journal of Fluorine Chemistry · 2020 · 309 citations
Fluorine-containing drugs approved by the FDA in 2021
Jingrui He, Ziyi Li, Gagan Dhawan et al. · Chinese Chemical Letters · 2022 · 164 citations